2-Nitro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline → HCID 67527994, compound
Reaction equation
[N+:1]([C:4]1[CH:9]=[C:8](B2OC(C)(C)C(C)(C)O2)[CH:7]=[CH:6][C:5]=1[NH2:19])([O-:3])=[O:2].Cl.Cl[C:22]1[CH:27]=[CH:26][N:25]=[C:24]([C:28]([F:31])([F:30])[F:29])[CH:23]=1>>[N+:1]([C:4]1[CH:9]=[C:8]([C:22]2[CH:27]=[CH:26][N:25]=[C:24]([C:28]([F:31])([F:30])[F:29])[CH:23]=2)[CH:7]=[CH:6][C:5]=1[NH2:19])([O-:3])=[O:2]Participants
3
Procedure
Following the procedure as described in Example 2, STEP A, the title compound was prepared from 2-nitro-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenylamine (0.300 g, 1.14 mmol, as prepared in the previous step) and 4-chloro-2-trifluoromethyl-pyridine hydrochloride (322 mg, 1.48 mmol) and was obtained as an orange solid.
Workup
- customwas obtained as an orange solid
Sources & evidence
- ORD record
- ord-84ea374aefcb4e99bb24181d6d2e9613
- Source dataset
- uspto-grants-2012_07
- Patent number
- US08217060B2
Reaction notes
Loading…